# Esketamine vs ECT for Acute Suicidality

> **NCT06355180** · NA · COMPLETED · sponsor: **Capital Medical University** · enrollment: 340 (actual)

## Conditions studied

- Mood Disorders
- Suicidal Ideation
- Depressive Episode

## Interventions

- **DRUG:** Esketamine
- **DEVICE:** Electroconvulsive therapy

## Key facts

- **NCT ID:** NCT06355180
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-16
- **Primary completion:** 2025-06-13
- **Final completion:** 2025-08-28
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06355180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06355180, "Esketamine vs ECT for Acute Suicidality". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06355180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*